Monitoring 400+ biotech tickers

Don't just trade dates.
Audit the evidence.

AI-powered biotech research that transforms SEC filings, insider trades, and clinical trial data into institutional-grade investment dossiers — with every claim backed by evidence citations.

Be first to get access. No spam — just a launch-day email.

Two Engines, One Edge

Near Real-Time

Flash Notes

Every SEC filing and clinical trial update is ingested and classified by AI. Only material changes that move the investment thesis are surfaced — filtering noise so you can focus on catalysts.

✓ Sentiment-tagged (Positive / Negative / Neutral)
✓ Filing type labeled (8-K, Form 4, 6-K, etc.)
✓ Expandable reasoning per note

Deep Analysis

Deep Audit Dossiers

AI synthesizes months of evidence — clinical protocols, insider trades, cash runway, institutional holdings — into a comprehensive dossier with integrity scoring and evidence citations on every claim.

✓ Clinical pipeline audit
✓ Red flag detection
✓ Catalyst roadmap
✓ Data integrity score

Comprehensive Data Ingestion

Every data source that matters for biotech equity research — ingested, parsed, and cross-referenced automatically.

8-K Current Reports

Material events — clinical readouts, FDA decisions, partnerships, leadership changes. Exhibit 99.1 press releases parsed for p-values and endpoint data.

10-Q & 10-K Financials

Quarterly and annual reports — risk factors, cash runway, burn rate, and collaborative agreement economics.

6-K & 20-F (FPI)

Full Foreign Private Issuer coverage — international biotechs like BioNTech, Novo Nordisk, and BeiGene.

Form 4 — Insider Trades

Real-time insider buy/sell signals — officer and director transactions filed within 2 business days.

13F-HR Holdings

Institutional ownership — quarterly 13F filings reveal hedge fund and mutual fund position changes.

S-3, F-3 & 424B Offerings

Shelf registrations and prospectus filings — early warning for dilutive equity offerings.

ClinicalTrials.gov

Active trial monitoring with protocol amendment detection — endpoint shifts, enrollment changes, status regressions.

Email Alerts

Instant dossier-ready notifications and daily flash digests delivered to your inbox — never miss a catalyst.

The Pro Edge

Features built specifically for biotech investors who need to see what others miss.

Protocol Amendment Detection

Detect silent changes in primary endpoints, enrollment targets, completion dates, eligibility criteria, and treatment arms — before the market notices.

Exhibit 99.1 Extraction

Parse press releases embedded in 8-K filings where actual p-values, clinical tables, and endpoint results live — beyond the headline.

Global FPI Coverage

Full support for Foreign Private Issuers via 6-K and 20-F filings. International biotech leaders get the same depth of analysis.

Silent Amendment Alerts

Flag trials where the update timestamp changed but no material fields moved — a classic signal of behind-the-scenes protocol adjustments.

Data Integrity Scoring

Every dossier receives an integrity score. Claims are cross-referenced against source documents with evidence citations. No unsupported assertions.

Red Flag Detection

Automated cross-reference anomaly detection — enrollment cuts paired with endpoint shifts, status regressions, or insider selling patterns.

Simple, Transparent Pricing

Preview our launch-day pricing. Join the waitlist to lock in early access.

Monthly Annual Save ~20%

Scout

$79/mo

~~$97/mo~~ · billed $948/yr

Less than $3.23/day

✓ 5 tickers
✓ Flash Notes
✓ 1 Deep Audit / month
✓ Email alerts
✓ All SEC filing types
✓ Clinical trial monitoring

Join the Waitlist

Be first in line.

Join biotech investors waiting for Catalyst Hunt to launch. Get early access — no spam, just a launch-day email.

Don't just trade dates. Audit the evidence.